Projects per year
Personal profile
Education/Academic qualification
Microbiology and Immunology, PhD, University of Florida Gaineseville
… → 1989
Molecular Biology, Master, Florida Institute of Technology
… → 1985
Biological Sciences with Honors, Bachelor, Florida Institute of Technology
… → 1983
External positions
IRTA Fellow, NIH NIAID
1993 → 1996
National Research Council Research Associate, NIH NIAID
1990 → 1992
Microbiologist, NIH NIAID
1989 → 1990
Postdoctoral Associate , University of Florida Gaineseville
1989
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Paramyxoviridae and Bunyavirales Vaccines and Antibodies Center (PABVAX)
Geisbert, T. W., Schaefer, B. B., Broder, C., Golovko, G., Crowe, J. E., Xu, K. K., Zeitlin, L., Falo, L. L. D. & Cross, R. W.
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
30/07/24 → 30/06/27
Project: Research
-
RP2: Vaccines and antibodies to henipavirus
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
1/03/24 → 28/02/25
Project: Research
-
-
Core A - Administrative Core
Broder, C. C. & Broder, C.
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
20/03/19 → 29/02/24
Project: Research
-
Project 3 - USUHS
Broder, C. C. & Broder, C.
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
20/03/19 → 29/02/24
Project: Research
-
A recombinant Cedar virus preclinical model that recapitulates neurological features of henipavirus disease
Huaman, C., Clouse, C., Rader, M., Strazzella, A. M., King, J., Santorella, E. M., Yan, L., Bai, S., Gunn, B. M., Amaya, M., Broder, C. C. & Schaefer, B. C., 17 Oct 2025, In: iScience. 28, 10, 113571.Research output: Contribution to journal › Article › peer-review
Open Access -
Clinical Characteristics and Outcomes of Cardiac Findings in Young Persons Following SARS-CoV-2 Infection
EPICC COVID-19 Cohort Study Group, 1 Apr 2025, In: Pediatric Infectious Disease Journal. 44, 4, p. 342-345 4 p.Research output: Contribution to journal › Article › peer-review
-
Development and Validation of a Differentiating Infected from Vaccinated Animals (DIVA) Enzyme-Linked Immunosorbent Assay (ELISA) Strategy for Distinguishing Between Hendra-Infected and Vaccinated Horses
McNabb, L., McMahon, A., Woube, E. G., Agnihotri, K., Colling, A., Broder, C. C., Kucinskaite-Kodze, I., Petraityte-Burneikiene, R., Bowden, T. R. & Halpin, K., Mar 2025, In: Viruses. 17, 3, 354.Research output: Contribution to journal › Article › peer-review
Open Access -
Development of a VSV-Hantavirus based screening platform to identify anti-hantavirus neutralizing human nanobodies.
Amaya, M., Dharmavaratha, P., Jays, A., Dimitrov, A. S., Broder, C., Leland, P. & Xu, J., 2025, (In preparation).Research output: Contribution to conference › Poster › peer-review
-
Experimental challenge of African green monkeys with contemporary Hendra virus isolates produces divergent clinical disease
Pigeaud, D. D., Fenton, K. A., Turcinovic, J., Borisevich, V., Agans, K. N., Deer, D. J., Harrison, M. B., Fears, A. C., Dobias, N. S., Prasad, A. N., Smith, I. L., Williams, D. T., Woolsey, C. B., Broder, C. C., Cross, R. W. & Geisbert, T. W., 2025, In: Emerging Microbes and Infections. 14, 1, 2544735.Research output: Contribution to journal › Article › peer-review
Open Access
Press/Media
-
CEPI Recognizes USU mAb for Nipah Virus as Top Force Health Innovation
1/01/26
1 item of Media coverage
Press/Media
-
CEPI Recognizes USU-Developed mAb Against Nipah Virus as a Top Innovation for Force Health Protection
1/01/26
2 items of Media coverage
Press/Media
-
CEPI Recognizes USU-Developed MAb Against Nipah Virus as a Top Innovation for Force Health Protection
25/04/25
1 item of Media coverage
Press/Media
-
CEPI RECOGNIZES USU-DEVELOPED MAB AGAINST NIPAH VIRUS AS A TOP INNOVATION FOR FORCE HEALTH PROTECTION
24/04/25
1 item of Media coverage
Press/Media
-
Breakthrough Discovery: New Treatment Offers Hope Against Deadly Nipah Virus
31/12/24
1 item of Media coverage
Press/Media